Skip to main content
[Preprint]. 2024 Jun 25:rs.3.rs-4542467. [Version 1] doi: 10.21203/rs.3.rs-4542467/v1

Figure 3:

Figure 3:

Lead T6Is and clinically relevant SERMs and SERDs inhibit WT and Y537S ERα-Coactivator binding. Clinically relevant A) SERD and B) SERM inhibition curves with WT-SRC3 binding. C) Rad1901 and T6Is inhibition curves for WT-SRC3 binding. D-F) Same as A-C, but with Y537S-SRC3 binding. Data are shown as the mean ± s.d.